These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3303431)

  • 21. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses.
    Germouty J; Jirou-Najou JL
    Respiration; 1987; 51 Suppl 1():37-41. PubMed ID: 3299566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
    Mashimo K
    Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
    [No Abstract]   [Full Text] [Related]  

  • 23. [penetration of fosfomycin into bronchial secretions].
    Berthelot G; Bergogne-Berezin E; Kafe H; Daumal M; Gillon JC
    Pathol Biol (Paris); 1983 Jun; 31(6):519-21. PubMed ID: 6348660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Problems in visiometry examining tracheo-bronchial-secretions (author's transl)].
    Heiden CL; Kornmesser HJ; Kretschmann A
    Laryngol Rhinol Otol (Stuttg); 1979 Mar; 58(3):264-8. PubMed ID: 439991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biochemical and enzymatic characteristics of bronchial secretions and their changes during treatment with mucolytic drugs].
    Olivieri D; Bocchino M; Marzo C
    Arch Monaldi; 1974; 29(3-4):283-308. PubMed ID: 4463914
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental studies on bronchial secretion. Therapeutical aspects of pathological bronchial secretion.
    Simonsson BG
    Scand J Respir Dis Suppl; 1974; 90():1-89. PubMed ID: 4618374
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modifiers of bronchial secretions in the asthmatic patient].
    Medici TC; Radielovic P
    Allergol Immunopathol (Madr); 1981; Suppl 9():201-6. PubMed ID: 7349729
    [No Abstract]   [Full Text] [Related]  

  • 28. The influence of seaprose on erythromycin penetration into bronchial mucus in bronchopulmonary infections.
    Braga PC; Piatti G; Grasselli G; Casali W; Beghi G; Allegra L
    Drugs Exp Clin Res; 1992; 18(3):105-11. PubMed ID: 1425205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic possibilities in chronic non-specific respiratory tract diseases. 1. Modification of secretion, inhalation- and respiration therapy, therapy of bronchial obstruction].
    Löllgen H; Löllgen-Horres I; von Nieding G
    Fortschr Med; 1976 Aug; 94(24):1276-84. PubMed ID: 786833
    [No Abstract]   [Full Text] [Related]  

  • 30. Nesosteine: a new mucoregulatory agent.
    Scuri R; Mondani P; Frova C; Fantini L
    Drugs Exp Clin Res; 1986; 12(8):663-70. PubMed ID: 3757762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics of antibiotics in bronchial secretions. 250 cases].
    Bergogne-Berezin E; Lambert-Zechovsky N; Morel C
    Nouv Presse Med; 1977 Nov; 6(38):3548. PubMed ID: 600730
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of the rheological properties of bronchial secretions in the mucociliary transport at the bronchial surface.
    Puchelle E; Polu JM; Zahm JM; Sadoul P
    Eur J Respir Dis Suppl; 1980; 111():29-34. PubMed ID: 6938407
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of ambroxol on lung tissue penetration of amoxicillin.
    Spátola J; Poderoso JJ; Wiemeyer JC; Fernández M; Guerreiro RB; Corazza C
    Arzneimittelforschung; 1987 Aug; 37(8):965-6. PubMed ID: 3675694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative histochemical study of the mechanism of action of 2 synthetic mucolytic agents, NA 872 and NA 274].
    Pesce Delfino V; Ricco R
    Pathologica; 1981; 73(1027):785-91. PubMed ID: 7342034
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of acetylcysteine by oral administration in bronchopneumophthiseology. Double blind controlled test concerning its effects on stagnation patterns of bronchial secretions].
    Grassi C; Morandini GC; Frigerio G
    Minerva Med; 1973; 64(45):2345-60. PubMed ID: 4582181
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacology of mucociliary transport].
    Lurie A; Pascal O; Castillon du Perron M; Grandordy B; Huchon G; Chrétien J
    Rev Mal Respir; 1985; 2(3):117-26. PubMed ID: 4081277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental studies on the influence of selected preparations on secretion of tear fluid. I. Schirmer test I and lysozyme test].
    Oleszczyńska-Prost E
    Klin Oczna; 1994 Jan; 96(1):5-7. PubMed ID: 7915765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambroxol for prophylaxis and treatment of bronchopulmonary complications after chest surgery.
    Romanini BM; Sandri MG; Tosi M; Mezzetti M; Mazzetti A
    Int J Clin Pharmacol Res; 1986; 6(2):123-7. PubMed ID: 3522443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possibility of interaction among antibiotics and mucolytics in children.
    Principi N; Zavattini G; Daniotti S
    Int J Clin Pharmacol Res; 1986; 6(5):369-72. PubMed ID: 3781700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathophysiological significance of the determination ofthe glucocorticoid concentration in bronchial secretions in children with bronchopulmonary diseases].
    Gavalov SM; Smirnova LP; Gizamulin ZIa; Egunova SM; Muravleva GG
    Vopr Med Khim; 1984; 30(2):37-40. PubMed ID: 6740993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.